Everything you need to know about the VITALDOCTOR platform, security
standards, and seamless medical integrations.
Quick answers to common inquiries regarding our technology and standards.
VITALDOCTOR is currently in the final stages of clinical validation and certification under the European MDR (Medical Device Regulation). Pilot projects are already running successfully in hospitals and care facilities. Commercial availability is expected soon. Interested institutions can already register for early access or participate in ongoing pilot programs
VITALDOCTOR is designed for hospitals, nursing homes, and outpatient care providers. It can be used for continuous monitoring of patients on normal wards, in long-term care facilities, or in telemedical settings. The system is intentionally simple to operate; it can be managed by trained healthcare staff without any technical expertise.
Traditional systems often rely on cables, manual measurements, and stationary monitors. VITALDOCTOR eliminates these barriers: it measures vital parameters wirelessly and automatically, transmits them in real time to the secure VITALDOCTOR Cloud, and uses intelligent triage to highlight critical cases. This means less manual effort, fewer errors, and faster response times, resulting in more efficient and safer patient care.
Yes. All data is transmitted encrypted and stored securely in the VITALDOCTOR Cloud, which complies with GDPR and medical data protection standards. Access is strictly controlled and limited to authorized personnel only. Data integrity and patient privacy are top priorities in our system design.
Yes. All data is transmitted encrypted and stored securely in the VITALDOCTOR Cloud, which complies with GDPR and medical data protection standards. Access is strictly controlled and limited to authorized personnel only. Data integrity and patient privacy are top priorities in our system design.
The use of VITALDOCTOR significantly improves patient safety, reduces workload, and lowers long-term treatment costs. Discussions with insurers and health authorities are ongoing to include the system in reimbursement programs. We are confident to offer this option soon.
By automating routine measurements, triage, and documentation, VITALDOCTOR allows caregivers and nurses to focus on direct patient care rather than administrative tasks. Facilities using VITALDOCTOR report reduced stress levels, faster response to emergencies, and improved quality of care — all key factors in addressing the staffing crisis.
Can’t find the answer you’re looking for? Please Contact our Team
Leading the transition to personalized, genomic-informed healthcare through innovation and empathy.
© 2026 VITALDOCTOR Inc. All rights reserved.
Dr. Ariane HackCMO Dr. Ariane Hack is a general practitioner and medical doctor with a Ph.D., possessing many years of experience in various medical facilities as well as in her own practice. Through her work across different healthcare settings, she has gained a broad understanding of clinical processes and the practical demands of everyday medical practice. At VITALDOCTOR, she contributes her medical expertise particularly to the validation of concepts and the development of product-oriented ideas. In addition, she oversees product and data validation, ensuring that technological solutions are aligned with real clinical needs and are practical for everyday use. |
 |
Heiner LuntzCFO Heiner Luntz is the CFO of VITALDOCTOR and has many years of experience in the financial management of companies with revenues in the hundreds of millions. He previously served as CFO at international companies with several hundred to over a thousand employees and brings extensive expertise in financial management, controlling, accounting, and corporate development. He is also a certified public accountant. At VITALDOCTOR, Heiner Luntz contributes his experience to the further development of financial structures and financial planning, as well as to strategic issues related to growth and financing. His many years of experience working within large corporate structures provide the team with sound financial insights. |
 |
Markus WiegmannCSO As a highly experienced manager with over 30 years in the medtech industry, Markus Wiegmann brings a wealth of experience to VITALDOCTOR. After holding positions at companies such as aap Implantate and ulrich medical, he most recently spent over 20 years at Stryker Corporation, a leading global medtech group with annual revenue of approximately $25 billion. There, among other roles, he held a leadership position in strategic corporate development and M&A and was responsible for the integration and acquisition of new companies and technologies to support Stryker’s strategic corporate development. Most recently, he served as Managing Director for the DACH region and Poland. In addition, as an elected board member of BVMed, he was actively involved in the German healthcare industry. |
 |
Dr. Konstantin SchönbornBeiratsvorsitzender Dr. Konstantin Schönborn studied law at the universities of Würzburg, Madrid, and Kiel, and earned his doctorate in Kiel. He has been a partner at Pava Partners since 2005 and has over 20 years of M&A experience in the medical technology sector. Thanks to his outstanding network in this sector, he is able to open doors for German-speaking companies to globally active medtech corporations. Dr. Konstantin Schönborn serves on the advisory boards of several companies in Germany and Austria. |
 |
Jonathan BotchouaCEO Jonathan Botchoua is the co-founder and CEO of VITALDOCTOR GmbH and a national award winner in mathematics in Germany. He has a background in electrical engineering and is also a software and AI developer, specializing in data processing, analysis, and the design and visualization of complex systems and data-driven applications. At VITALDOCTOR, he is responsible for the company’s strategic direction as well as the development and scaling of digital health solutions. This includes, in particular, the establishment and further development of the business model, the management of core business processes, and the operational implementation at the intersection of technology, medicine, and regulation. |
 |